Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |